文献速递免疫规划卫生政策与健康促进

评估用于COVID-19疫苗接种的原型净化移动单元(UMDEO):法国一项横断面调查

Evaluation of a prototype decontamination mobile unit (UMDEO) for COVID-19 vaccination: A cross-sectional survey in France.
PubMed 文献 · Vaccine · 2021-11-03

本研究在法国图卢兹开展为期两天的描述性横断面调查,评估原型净化移动单元(UMDEO)作为COVID-19疫苗接种点的感知有用性。共1409名接种者(84.9%)和68名团队人员(80%)填写问卷,多数参与者认可以下两点:该单元增加接种可及性、加快整体接种活动。

要点

  • 1409名接种者中93.2%认为移动单元增加了接种可及性,68名团队人员中98.5%持相同看法。
  • 91.3%接种者(n=1281)和95.6%团队人员(n=65)认为该单元会加快整体接种活动。
  • UMDEO作为5排疫苗接种单元运行,患者最大接种速率为每小时98人。

核心结论

  • 多数接种者和参与调查的团队人员对UMDEO作为疫苗接种中心的有用性表示满意。
  • 图卢兹是目前唯一使用此类结构进行疫苗接种的城市,但作者认为它可作为规划其他移动单元以增加接种可及性的基础。

研究设计与样本

  • 描述性横断面研究,在法国图卢兹开展两天。
  • UMDEO为一种全面、多用途的解决方案,部署为5排疫苗接种单元。
  • 2021年3月6日至7日向所有到移动中心接种的患者及参与接种活动的团队发放书面问卷。
  • 接种患者共1659名,其中1409名(84.9%)填写问卷;UMDEO团队85人中68人(80%)填写问卷。

主要发现

  • 患者最大接种速率为每小时98人。
  • 多数参与者和照护者(分别为1307人[93.2%]和67人[98.5%])同意移动单元增加了接种可及性。
  • 91.3%患者(n=1281)和95.6%照护者(n=65)认为该单元会加快整体接种活动。

临床怎么用

  • 作者认为UMDEO可作为规划其他移动单元以增加接种可及性的基础。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM OF THE STUDY: In the context of the worldwide vaccination campaign against COVID-19, France has been deploying multiple sites for mass vaccination. This study aimed to assess the perceived usefulness of a prototype decontamination mobile unit (UMDEO) for COVID-19 vaccination among both the patient and healthcare providers perspectives. METHODS: This was a descriptive cross-sectional study conducted in Toulouse over two days. UMDEO is a fully comprehensive, versatile solution that was deployed as a 5-row vaccination unit. A written questionnaire was distributed from March 6th-7th, 2021 among all patients presenting for vaccination at the mobile center, as well as the team participating in the vaccination campaign. RESULTS: Among the vaccinated patients (n = 1659), 1409 participants (84.9%) filled out the survey, as well as 68 out of 85 (80%) within the UMDEO team. The maximum patient rate was 98 people per hour. The majority of participants and caregivers (1307 [93.2%] and 67 [98.5%] respectively) agreed that the mobile unit increased access to vaccination. A total of 91.3% patients (n = 1281) and 95.6% caregivers (n = 65) believed that it would speed up the overall vaccination campaign. CONCLUSION: The majority of the vaccinated population and of the team participating in the survey were satisfied with the usefulness of UMDEO as a vaccination center. Toulouse is currently the only city to have used such a structure for vaccination, but it could be used as a basis for planning other mobile units to increase vaccination access.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Ribera-Cano A, Dupont M, Houzé-Cerfon CH, et al. Evaluation of a prototype decontamination mobile unit (UMDEO) for COVID-19 vaccination: A cross-sectional survey in France. Vaccine. 2021. PMID: 34782160. doi:10.1016/j.vaccine.2021.10.080

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。